Prognosis of Dental Implants In Diabetic Patients
DOI:
https://doi.org/10.52783/jns.v14.3184Keywords:
timplan, diabetes, prognosisAbstract
Background: This study had been carried out to evaluate the prognosis of dental implants in subjects suffering from diabetes
mellitus.
Material and methods: A total of 100 individuals participated in the study, which was divided into two distinct groups. The
first group comprised 50 healthy participants, while the second group consisted of 50 individuals diagnosed with diabetes.
The study focused on patients who had partially missing maxillary and/or mandibular arches and subsequently received oral
rehabilitation through dental implants. Relevant medical histories, dental radiographs, and clinical records were collected for
these patients. The classification into healthy and diabetic groups was based on the evaluation of glycated haemoglobin
(HbA1c) levels at the time of implant placement. According to the criteria established by the American Diabetes Association
(ADA), individuals with HbA1c levels below 6.5% are categorized as non-diabetic (healthy), whereas those with levels
exceeding 6.5% are classified as diabetic.
Results: There were 75 females and 25 males in this study. The success rate of dental implants in the control group as well
as case group was 96% and 72%, accordingly. Most of the implants had been placed in the mandible (85%) as compared to
maxilla (15%).
Conclusion: The findings of this study indicate that individuals with diabetes mellitus have a favourable prognosis regarding
dental implants.
Downloads
Metrics
References
WHO. Global Report on Diabetes. Geneva, Switzerland: World Health Organization; 2016.
International Diabetes Federation. IDF Diabetes Atlas. 8th ed. International Diabetes Federation, Brussels,
Belgium: 2017.
Sghaireen MG, Alduraywish AA, Srivastava KC, Shrivastava D, Patil SR, Al Habib S, et al. Comparative
evaluation of dental implant failure among healthy and well-controlled diabetic patients-A 3-year retrospective
study. Int J Environ Res Public Health. 2020;17:5253.
Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the
hospital. Lancet Diabetes Endocrinol. 2021;9:174–88.
Magliano DJ, Islam RM, Barr ELM, Gregg EW, Pavkov ME, Harding JL, et al. Trends in incidence of total or
type 2 diabetes: Systematic review. BMJ. 2019;366:l5003.
International Diabetes Federation . IDF Diabetes Atlas. 8th ed. International Diabetes Federation; Brussels,
Belgium: 2017.
Magliano D.J., Islam R.M., Barr E.L.M., Gregg E.W., Pavkov M.E., Harding J.L., Tabesh M., Koye D.N., Shaw
J.E. Trends in incidence of total or type 2 diabetes: Systematic review. BMJ. 2019;366 doi: 10.1136/bmj.l5003.
Singh A, Agarwal M, Prasad A. Analysis of effect of diabetes on outcome of dental implant therapy. J Adv
Med Dent Sci Res. 2020;8(2):32–6.[9] Naujokat H, Kunzendorf B, Wiltfang J. Dental implants and diabetes mellitus-a systematic review. Int J Implant
Dent. 2016;2(5):19–22.
Sharma A, Deo A, Sharma A, Kumar D, Gupta P, Cheema M. Assessment of Prognosis of Dental Implants in
Diabetic Patients: A Clinical Study. J Pharm Bioallied Sci. 2023;15(Suppl 2):S920-S922.
Andrade CAS, Paz JLC, de Melo GS, Mahrouseh N, Januário AL, Capeletti LR. Survival rate and peri-implant
evaluation of immediately loaded dental implants in individuals with type 2 diabetes mellitus: a systematic
review and meta-analysis. Clin Oral Investig. 2022;26(2):1797-1810.
Olson JW, Shernoff AF, Tarlow JL, Colwell JA. Dental endosseous implant assessments in a type 2 diabetic
population: A prospective study. Int J Oral Maxillofac Implants. 2000;15:811–8.
Al Amri MD, Abduljabbar TS, Al-Johany SS, Al Rifaiy MQ, Alfarraj Aldosari AM, Al-Kheraif AA.
Comparison of clinical and radiographic parameters around short (6 to 8 mm in length) and long (11 mm in
length) dental implants placed in patients with and without type 2 diabetes mellitus: 3-year follow-up results.
Clin Oral Implants Res. 2017;28(10):1182–7.
Cabrera-Domínguez JJ, Castellanos-Cosano L, Torres-Lagares D, Machuca-Portillo G. A prospective case
control clinical study of titanium-zirconium alloy implants with a hydrophilic surface in patients with type 2
diabetes mellitus. Int J Oral Maxillofac Implants. 2017;32(5):14–9.
Marconcini S, Giammarinaro EE, Correia JA, Maltagliati A, Salvado F, Covani U. Clinical performance of
titanium-zirconia tissue-level implants in patients with well-controlled and poorly controlled type 2 diabetes: a
cohort study with chair-side assessment of oxidative stress.: titanium-zirconia implants in diabetic patients. Oral
Implantol. 2022;15(1):21–4.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
